Medicine and Dentistry
Abdominal Hysterectomy
8%
Adenocarcinoma
10%
Assisted Reproductive Technology
21%
Autofluorescence
15%
Biological Marker
20%
Biopsy
22%
Birth Weight
11%
Bleeding
11%
Body Mass Index
10%
Brain Imaging
8%
Breast Cancer
20%
CA-125
8%
Cancer
24%
Cancer Cell
11%
Cancer Diagnosis
15%
Cancer Risk
8%
Carcinogenesis
14%
Carcinoma
10%
Cell Function
12%
Cervical Cancer
47%
Cervical Intraepithelial Neoplasia
12%
Cervix
29%
Childbirth
17%
Chorionic Gonadotropin
13%
Colon
12%
Colon Cancer
11%
Colony Stimulating Factor 1
9%
Colposcopy
8%
Community Health
14%
COVID-19
21%
COVID-19 Vaccination
8%
Cytotechnology
11%
Diagnosis
21%
Disease
54%
Dysplasia
9%
Endometrial Cancer
10%
Endometriosis
33%
Endometrium
9%
Endometrium Carcinoma
11%
Endoscope
24%
Endoscopy
8%
Ex Vivo
21%
Extracellular Matrix
9%
Fallopian Tube
24%
Female Genital Tract Cancer
19%
Fetus Growth
11%
Folic Acid
8%
Gene Linkage
13%
Gestational Trophoblastic Disease
13%
Gynecological Oncology
23%
Hazard Ratio
16%
Health Care
8%
Hysterectomy
11%
In Vitro
23%
Infection
13%
Insulin Release
33%
Intrauterine Growth Retardation
28%
Krukenberg Tumor
15%
Laser Induced Fluorescence
17%
Laser Induced Fluorescence Spectroscopy
8%
Malignant Neoplasm
62%
Menstrual Cycle
15%
Metastatic Carcinoma
21%
Methotrexate
10%
Multiphoton Microscopy
10%
Neoplasm
37%
Noradrenalin
8%
Nurse
9%
Obstetrics
13%
Odds Ratio
12%
Optical Coherence Tomography
43%
Ovarian Cancer
100%
Ovariectomy
13%
Pancreatic Islet
19%
Papillomavirus Infection
11%
Patient Referral
11%
Pelvis
28%
Placental Insufficiency
14%
Postmenopause
8%
Pregnancy
14%
Premature Labor
21%
Prevalence
8%
Prospective Cohort Study
22%
Proto Oncogene
9%
Radiation Therapy
17%
Radical Hysterectomy
15%
Recurrent Disease
20%
Reoperation
10%
Retroperitoneal Lymph Node Dissection
8%
Serous Carcinoma
10%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Spectrofluorometry
10%
Squamous Cell Carcinoma
19%
Surgery
18%
Symptom
12%
Trophoblastic Disease
8%
Uterine Cervix Dysplasia
9%
Vascularity
10%
Wart Virus
15%
Women's Health
18%
Keyphrases
Adverse Effects
5%
Anti-Mllerian Hormone
8%
Arizona
8%
Assisted Reproductive Technology
6%
Autofluorescence
7%
Bragg
5%
Cervical Cancer
26%
Cervical Carcinoma
7%
Cervical Dysplasia
6%
Cervical Intraepithelial Neoplasia
9%
Chemotherapy
14%
Cisplatin
12%
Community Health Workers
5%
Community Linkages
5%
Condyloma Acuminatum
8%
Confidence Interval
21%
Diethylstilbestrol
5%
Dual-modal Imaging
5%
Early Invasive Strategy
5%
Endogenous Contrast
5%
Endogenous Fluorescence
7%
Endometrial Cancer
9%
Endometriosis
10%
Endometrium
9%
Endoscope
8%
Epithelial Ovarian Cancer
6%
Female Firefighters
8%
Fetal Sheep
11%
Fetus
13%
Fluorescence Spectroscopy
9%
Gestational Trophoblastic Disease
5%
Group Studies
14%
Gynecologic Oncology Group
17%
Gynecological Cancer
11%
Hazard Ratio
7%
High numerical Aperture Objective
5%
High Selectivity
5%
High-risk Human Papillomavirus (HR-HPV)
8%
Histology
7%
Hologram
5%
Hormone Levels
9%
Human Ovarian Cancer
5%
Hysterectomy
8%
Image Contrast
5%
Image Information
5%
Image Processing
5%
Imaging Instrument
5%
Imaging Techniques
5%
Infertility
21%
Insulin Secretion
12%
Intrauterine Growth
7%
Islet
9%
Laparotomy
7%
Laser-induced Fluorescence
5%
Mobile Platform
5%
Mouse Model
12%
Multicolor Fluorescence Imaging
8%
Multiphoton Imaging
5%
Multiphoton Microscopy
7%
Neovagina
5%
Nurses' Health Study
7%
Nutritional Status
5%
OCT Probe
5%
Oncologic
5%
Oophorectomy
5%
Optical Coherence Tomography
25%
Ovarian Cancer
26%
Ovarian Cancer Risk
9%
Ovarian Cancer Screening
9%
Ovarian Tissue
8%
Papillomavirus Infections
6%
Pelvic Exenteration
5%
Phase II Study
7%
Post-acute Sequelae of COVID-19 (PASC)
5%
Pregnancy Outcome
8%
Preterm Birth
6%
Prospective Cohort Study
6%
Q-switched Alexandrite Laser
5%
Radiation Therapy
6%
Radical Hysterectomy
7%
Registry Linkage
5%
Selective Intrauterine Growth Restriction (sIUGR)
9%
Squamous Cell Carcinoma of the Cervix
6%
Tissue Imaging
5%
Tissue Model
6%
Tryptophan Fluorescence
5%
Tubal Ligation
7%
Tumor
10%
Ultrasound Tomography
5%
US-Mexico Border
8%
Verruca Plantaris
5%
Viable Tissue
5%
Vigilin
5%
Volume Hologram
5%
Volume Holographic Imaging
8%
Women's Health Initiative
9%